C. Hermans
Impact in
-
- Sarcoma Diagnosis and Treatment
- Oncology top 5%
- Vascular Tumors and Angiosarcomas
- CAR-T cell therapy research
Papers in
-
- Sarcoma Diagnosis and Treatment 11
- Oncology 10
- Vascular Tumors and Angiosarcomas 9
- Co-authors
- Ian Judson (10 shared papers)Jean‐Yves Blay (8 shared papers)Jaap Verweij (7 shared papers)Pancras C.W. Hogendoorn (2 shared papers)M. van Glabbeke (8 shared papers)Sandrine Marréaud (3 shared papers)Thierry Alcindor (1 shared paper)Hans Gelderblom (1 shared paper)
- Journals
- European Journal of Cancer (6 papers)Journal of Clinical Oncology (3 papers)The Lancet Oncology (1 paper)Anti-Cancer Drugs (1 paper)Journal of Quantitative Spectroscopy and Radiative Transfer (1 paper)
- Partner nations
- BelgiumUnited KingdomNetherlands
In The Last Decade
C. Hermans
12 papers receiving 1.9k citations
C. Hermans's Hit Papers
Peers
Comparison fields: 5 of 87
- Pulmonary and Respiratory Medicine 1.2k
- Oncology 753
- Gastroenterology 111
- Cardiology and Cardiovascular Medicine 356
- Astronomy and Astrophysics 180
Countries citing papers authored by C. Hermans
This map shows the geographic impact of C. Hermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Hermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Hermans more than expected).
Fields of papers citing papers by C. Hermans
This network shows the impact of papers produced by C. Hermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Hermans. The network helps show where C. Hermans may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Hermans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial Hit paper breakdown → | 2014 | 827 |
| 2 | 2001 | 301 | |
| 3 | 2011 | 253 | |
| 4 | 2000 | 186 | |
| 5 | 2002 | 130 | |
| 6 | 2000 | 108 | |
| 7 | 2002 | 96 | |
| 8 | 1999 | 53 | |
| 9 | 1999 | 13 | |
| 10 | 2006 | 11 | |
| 11 | 2006 | 7 | |
| 12 | 2005 | 3 |
About C. Hermans
C. Hermans is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Pathology and Forensic Medicine and Surgery, having authored 12 papers that have together received 2.0k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (11 papers), Vascular Tumors and Angiosarcomas (9 papers), Lymphoma Diagnosis and Treatment (3 papers), Colorectal and Anal Carcinomas (2 papers), Renal and related cancers (2 papers), Advanced Chemical Physics Studies (1 paper), Gastrointestinal Tumor Research and Treatment (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Oncology (753 citations), Gastroenterology (111 citations), Cardiology and Cardiovascular Medicine (356 citations) and Astronomy and Astrophysics (180 citations). C. Hermans has collaborated with scholars based in Belgium, United Kingdom and Netherlands. Frequent co-authors include Ian Judson, Jean‐Yves Blay, Jaap Verweij, Pancras C.W. Hogendoorn, M. van Glabbeke, Sandrine Marréaud, Thierry Alcindor, Hans Gelderblom, Peter Hohenberger and Patrick Schöffski. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, The Lancet Oncology, Anti-Cancer Drugs and Journal of Quantitative Spectroscopy and Radiative Transfer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.